
A central resource for insights, guidance, and practical breast imaging support.
KNOWLEDGE HUB
Resources
A growing library of practical insights, guides, and operational resources to help imaging centers improve follow-up, strengthen compliance, and make smarter decisions with confidence.

A central resource for insights, guidance, and practical breast imaging support.
KNOWLEDGE HUB

In-depth resources on patient tracking, follow-up workflow management, and preventing patients from falling through the cracks.
MAMMOTRACK

Guides on lay communication letters, patient notification workflows, MQSA communication requirements, and outreach best practices.
MAMMOCOMMUNICATE

Resources for breast imaging navigators — follow-up coordination, 30-60-90 day models, patient support, and closing care gaps.
MAMMONAVIGATE

Practical guidance on MQSA compliance, accreditation-related reporting, audit preparation, and documentation that stands up to review.
MAMMOCOMPLY

Home of BINA Voices: Bridging Care, Knowledge & Support in Breast Imaging — the podcast from the Breast Imaging Navigation Alliance, supported by Mammologix.
MAMMOSTUDIO

Real-world stories from breast imaging facilities — anonymized accounts of how tracking, follow-up, communication, and compliance challenges unfold in practice.
BEYOND THE MAMMOGRAM

Short video resources on breast imaging workflow, MQSA compliance, patient follow-up, and Mammologix operational support in action.
VIDEOS

Your central hub for mammography calculators, compliance resources, policy tools, and practice guides.
MAMMOTOOLBOX
Knowledge Base
Outcome-dependent audit metrics — CDR, PPV, sensitivity, specificity — can't be final until the one-year cancer outcome window closes. A case in your false-positive column today might be a true positive by year-end.
AI won't replace the Gail or Tyrer-Cuzick risk calculators — it adds a mammogram-derived score alongside them. Here's what managing multiple risk estimates means operationally for breast imaging programs.
Two words breast imaging results letters reach for first — positive and negative — mean the opposite to most patients of what they mean clinically. Here is what the evidence shows and what plain language looks like instead.
One outcome label in the record can sit on top of more than forty different situations. Only a handful are a choice the patient made. Here is the complete list of what "non-compliant" actually hides, and the reason each case deserves instead.
A breast imaging practice told 3,686 women after a normal 2022 mammogram to come back in a year — then followed every one of them forward through May 2026. Two findings stand out: among the women who returned, the annual rhythm is genuinely strong. And a large, quiet group did not come back at all.
We've gotten good at spotting who slipped through. What we've built almost nothing to capture is the reason she didn't return — and the reason is the only thing that sets every next move.
Mammography is the only field in U.S. medicine with a federally required diagnostic-safety system, in place since 1992. The September 10, 2024 MQSA Final Rule made that system inspectable. Whether a breast imaging practice honors it now depends on the back office.
FDA launched a one-day inspectional assessment pilot in April 2026. Here is what mammography facilities need to know about MQSA implications, NAI outcomes, and continuous inspection readiness.
A regulatory risk analysis of four convergent threats to U.S. breast cancer screening infrastructure in 2026 — USPSTF administrative disruption, MQSA enforcement continuity, the anti-over-medicalization cultural narrative, and their cascade interaction — with institutional response recommendations for breast imaging program leadership.
Four distinct forces are putting simultaneous pressure on breast imaging programs — USPSTF meeting disruptions, MQSA enforcement uncertainty, cultural headwinds against organized screening, and their combined cascading effect. A plain account of what is happening and where to focus.
Patient compliance with recommended interval follow-up studies following a mammographic screening result is a critical public health challenge. This paper examines the three most consequential determinants of compliance as mediated through the written notification letter: health literacy alignment, emotional tone calibration, and the specificity and actionability of the clinical call to action.
Breast MRI outcome auditing is not MQSA-mandated but is expected under ACR accreditation. This in-depth guide covers the three-stream audit architecture — screening, diagnostic, and preoperative MRI — with the ACR BI-RADS® two-tier benchmark framework, BCSC reference values, illustrative examples, and statistical interpretation guidance.
Our team has supported breast imaging centers since 1995. If it's not here, we probably know the answer.